University of Maryland Medical Center SC -1
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Feliciano, Josephine
REACTION, NCT03610711: (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer

Active, not recruiting
1/2
21
US
Nivolumab, Optivo, Relatlimab, anti-LAG3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bristol-Myers Squibb
Gastroesophageal Cancer, Immune Checkpoint Inhibition
12/25
12/25
REACH PC, NCT03375489: Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Active, not recruiting
N/A
1250
US
Telehealth, In-person PC
Massachusetts General Hospital, Patient-Centered Outcomes Research Institute, Palliative Care Research Cooperative Group
Lung Cancer
12/23
12/24
NCT06791057: Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Not yet recruiting
N/A
420
US
Dyspnea Intervention, Enhanced Usual Care
Massachusetts General Hospital, Johns Hopkins University, University of Miami, National Cancer Institute (NCI)
Advanced Lung Cancer, Dyspnea
12/29
03/30

Download Options